Generic drugmaker Sandoz's shares fall after sales outlook lowered
Published . Updated .
Covered by 2 outlets: Euronext Markets: Real-time Stock Market Data | live, Reuters.
Who covered it: Center 1 · Not rated 1. How we rate outlets
ZURICH, Oct 28 (Reuters) - Swiss generic drugmaker Sandoz on Wednesday lowered its full-year sales growth guidance and lifted its core earnings margin forecasts after short-term biosimilar-supply constraints weighed on third-quarter results, sending shares down over 5% in early
Directly affected
- No company is named in this report.
Indirectly affected
- EWL iShares MSCI Switzerland ETF
iShares MSCI Switzerland ETF holds stocks listed in Switzerland, which this story is about (“swiss”).
- NVS Novartis AG+1.3% 17d
Novartis AG (pharmaceutical preparations) is one of the largest Switzerland-based companies traded in the US, so news about Switzerland (“swiss”) reaches its shares.
- CB Chubb+5.7% 30d
Chubb (fire, marine and casualty insurance) is one of the largest Switzerland-based companies traded in the US, so news about Switzerland (“swiss”) reaches its shares.
- BG Bunge Global-18.0% 30d
Bunge Global (fats and oils) is one of the largest Switzerland-based companies traded in the US, so news about Switzerland (“swiss”) reaches its shares.
- ONON On Holding AG+20.8% 30d
On Holding AG (rubber and plastics footwear) is one of the largest Switzerland-based companies traded in the US, so news about Switzerland (“swiss”) reaches its shares.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| EWLNo price data for this ticker | — | — | — | — | — | — | — |
| NVSNo price data for this ticker | — | — | — | — | — | — | — |
| CBNo price data for this ticker | — | — | — | — | — | — | — |
| BGNo price data for this ticker | — | — | — | — | — | — | — |
| ONONNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Generic drugmaker Sandoz's shares fall after sales outlook lowered Euronext Markets: Real-time Stock Market Data | live
Source: Euronext Markets: Real-time Stock Market Data | live
Congressional trades in the stocks in this story
- Rep. Kevin Hern sold Novartis Ag (NVS), worth $15,001 - $50,000 on 27 Aug 2026. That is 62 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Chubb (CB), worth $1,001 - $15,000 on 24 Sep 2026. That is 34 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Chubb (CB) (jointly held), worth $1,001 - $15,000 on 23 Sep 2026. That is 35 days before publication. Filed 13 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Chubb (CB) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
25 out of 100
“Generic drugmaker Sandoz's shares fall after sales outlook lowered” scores 25 out of 100. The score uses 2 sources.